{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:05:25Z","timestamp":1761807925110},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000},"content-version":"vor","delay-in-days":341,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"CAPES and Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de S\u00e3o Paulo\u2014FAPESP","award":["08\/50423-7 to ASP"],"award-info":[{"award-number":["08\/50423-7 to ASP"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ejphar.2015.01.010","type":"journal-article","created":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T04:17:43Z","timestamp":1421900263000},"page":"39-42","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Involvement of \u03b11B-adrenoceptors in the anti-immobility effect of imipramine in the tail suspension test"],"prefix":"10.1016","volume":"750","author":[{"given":"Carlos Alberto S.","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 S.","family":"Pupo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2015.01.010_bib1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s007020170047","article-title":"Pharmacotherapy of depression: a historical analysis","volume":"108","author":"Ban","year":"2001","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2015.01.010_bib2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2009.06.035","article-title":"Alpha(1A)- and alpha(1B)-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse","volume":"1285","author":"Doze","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2015.01.010_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1056-8719(98)00035-5","article-title":"Characterization of 5-HT1A receptor functional coupling in cells expressing the human 5-HT1A receptor as assessed with the cytosensor microphysiometer","volume":"40","author":"Dunlop","year":"1998","journal-title":"J. Pharmacol. Toxicol Methods"},{"key":"10.1016\/j.ejphar.2015.01.010_bib4","first-page":"97","article-title":"Antagonism by antidepressants of muscarinic acetylcholine receptors of human brain","volume":"78","author":"El-Fakahany","year":"1983","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.01.010_bib5","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/0014-2999(94)00751-R","article-title":"BMY 7378 is a selective antagonist of the D subtype of alpha 1-adrenoceptors","volume":"272","author":"Goetz","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.01.010_bib6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0278-5846(91)90011-O","article-title":"Behavioral models in mice. Implication of the alpha noradrenergic system","volume":"15","author":"Hascoet","year":"1991","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.01.010_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2007.01.063","article-title":"Involvement of dopamine D1 receptors and alpha1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test","volume":"562","author":"Hirano","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.01.010_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuropharm.2010.03.015","article-title":"The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat alpha1B-adrenoceptors","volume":"59","author":"Nojimoto","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2015.01.010_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cne.20992","article-title":"Localization of the mouse alpha1A-adrenergic receptor (AR) in the brain: alpha1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors","volume":"497","author":"Papay","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2015.01.010_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.20215","article-title":"Mouse alpha1B-adrenergic receptor is expressed in neurons and NG2 oligodendrocytes","volume":"478","author":"Papay","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2015.01.010_bib11","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1021\/jm980053f","article-title":"4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)-[[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist","volume":"41","author":"Patane","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2015.01.010_bib12","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/sj.bjp.0702735","article-title":"Effects of indoramin in rat vas deferens and aorta: concomitant alpha1-adrenoceptor and neuronal uptake blockade","volume":"127","author":"Pupo","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.01.010_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/274176a0","article-title":"Tricyclic antidepressants block histamine H1 receptors of mouse neuroblastoma cells","volume":"274","author":"Richelson","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2015.01.010_bib14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0306-4522(98)00616-2","article-title":"Expression of alpha1D adrenergic receptor messenger RNA in oxytocin- and corticotropin-releasing hormone-synthesizing neurons in the rat paraventricular nucleus","volume":"91","author":"Sands","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2015.01.010_bib15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.ejphar.2015.01.010_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/syn.10127","article-title":"Role of brain alpha 1B-adrenoceptors in modafinil-induced behavioral activity","volume":"46","author":"Stone","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2015.01.010_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0028-3908(00)00151-9","article-title":"Pharmacological evidence for the role of central alpha 1B-adrenoceptors in the motor activity and spontaneous movement of mice","volume":"40","author":"Stone","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2015.01.010_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1017\/S1461145710000507","article-title":"Antidepressant-like action of intracerebral 6-fluoronorepinephrine, a selective full alpha-adrenoceptor agonist","volume":"14","author":"Stone","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2015.01.010_bib19","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0006-3223(99)00234-6","article-title":"Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression","volume":"46","author":"Stone","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.01.010_bib20","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bcp.2006.10.001","article-title":"Central alpha1-adrenergic system in behavioral activity and depression","volume":"73","author":"Stone","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.01.010_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1126\/science.202024","article-title":"Tricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain","volume":"199","author":"U\u2019Prichard","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2015.01.010_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00008877-200302000-00009","article-title":"The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test","volume":"14","author":"Varty","year":"2003","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.01.010_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.bjp.0702541","article-title":"In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists","volume":"127","author":"Williams","year":"1999","journal-title":"Br. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T04:59:49Z","timestamp":1537937989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":23,"alternative-id":["S0014299915000321"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.01.010","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of \u03b11B-adrenoceptors in the anti-immobility effect of imipramine in the tail suspension test","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}